Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Kangding Jinzhu Pharmaceutical is a specialized pharmaceutical company based in the Ganzi Tibetan Autonomous Prefecture of China, focusing on the modernization and production of Traditional Tibetan Medicine (TTM). The company manufactures a wide range of Chinese patent medicines and ethnic drugs, most notably its flagship products like the Twenty-five Flavors Coral Pill and the Twenty-five Flavors Turquoise Pill. These formulations are primarily utilized for treating neurological, cardiovascular, and hepatic conditions according to traditional practices. Operating with GMP-certified facilities, the company plays a significant role in the industrialization of Tibetan medicine within the Sichuan province. Its business model encompasses the entire value chain from the cultivation of high-altitude medicinal herbs to large-scale manufacturing and commercial distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Kangding Jinzhu Pharmaceutical.